Clinical Research

The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta is home to some of the top minds in childhood blood disorders. While our doctors, nurses and medical team provide exceptional treatment and tender care, dedicated researchers work passionately to find a cure. We provide our patients access to the latest treatment options by offering more than 200 therapeutic and non-therapeutic pediatric clinical trials.

Find a Clinical Trial

Visit our new online clinical trials database.

This tools allows you to easily search and view our open clinical trials. Here you will find a brief summary of each trial, objectives and eligibility criteria.

The Aflac Cancer Center actively participates in regional and national multi-institutional pediatric clinical trials and collaboration studies with the following:

  • National Institutes of Health (NIH)
  • National Heart Lung and Blood Institute (HHLBI)
  • Maternal and Child Health Bureau (MCHB)
  • Centers for Disease Control and Prevention (CDC)
  • Hemostasis and Thrombosis Research  Society (HTRS)
  • National Hemophila Foundation (NHF)
  • Hemophilia of Georgia (HOG)
  • American Heart Association

Basic science areas of interest include:

  • Why people with hemophilia develop inhibitors
  • Gene therapy for hemophilia A
  • Bleeding disorders associated with defects in platelets and their interaction with the blood vessel wall
  • Why people with hemophilia develop joint disease

Clinical areas of interest include:

  • Treatment of idiopathic thrombocytopenic purpura (ITP)
  • Treatment of patients with hemophilia who develop inhibitors
  • Reasons why patients who undergo extra corporeal membrane oxygenation (ECMO) might bleed
  • Understanding how best to take a bleeding history and evaluation of patients who bleed without a know diagnosis
  • Treatment of von Willebrand disease
  • Treatment of central lines and thrombosis
More information about pediatric research at the Aflac Cancer Center